Antinociceptive/anti-edema effects of liposomal morphine during acute inflammation of the rat paw

Pharmacology. 2000 Apr;60(3):121-7. doi: 10.1159/000028356.

Abstract

We evaluated the anti-edema/antinociceptive effects of subcutaneous free and liposomal morphine in rats with carrageenan-induced inflammation of the paw. We assessed antinociception by the paw pressure test and edema by plethysmography. Unilamellar liposomes (150-200 nm) with 0.3% morphine hydrochloride were used; encapsulation significantly reduced the rate for release of morphine in vitro. During inflammation, the antinociceptive potency of free, but not liposomal morphine increased 2.5 times; moreover, duration of the effects was prolonged by encapsulation (p < 0.001). The anti-edema effects of liposomal morphine were more pronounced (p < 0. 001) and of longer duration (p < 0.05). All the effects were reversed by naloxone. The results show that morphine encapsulation enhances the anti-edema effects and prolongs antinociception.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / pharmacology
  • Analgesics, Opioid / therapeutic use*
  • Animals
  • Carrageenan
  • Drug Carriers
  • Edema / chemically induced
  • Edema / drug therapy*
  • Liposomes
  • Male
  • Morphine / pharmacology
  • Morphine / therapeutic use*
  • Naloxone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Pain Measurement / drug effects
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Analgesics, Opioid
  • Drug Carriers
  • Liposomes
  • Narcotic Antagonists
  • Naloxone
  • Morphine
  • Carrageenan